Skip to content

Comparison of local versus systemic tranexamic acid in total knee replacement

The comparative Efficacy and Safety of Topical and Intravenous Tranexamic acid for Reducing Perioperative Blood Loss in Total Knee Arthroplasty- A Randomized Controlled Non-inferiority Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009076
Enrollment
113
Registered
2017-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primary Osteoarthritis Knee

Interventions

Intervention1: Intraarticular administration of tranexamic acid: 1.5g of TXA in 10 ml of normal saline injected into the joint through 18 gauge needle after wound closure before tourniquet release Con

Sponsors

SUNSHINE HOSPITALS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients undergoing total knee arthroplasty for primary arthroplasty knee 2.Patients who are willing to participate in the study. 3.Patient without exclusion criteria.

Exclusion criteria

Exclusion criteria: 1.Allergy to the TXA 2.H/O Coagulopathy,abnormal PT or APTT 3.Past H/O Thromboembolic event 4.Treatment with Aspirin or NSAIDS in the last week 5.plasma creatinine > 115 micro moles /litre for males And >100 micro moles/litre in females. 6.Acute infection[eg;leukocytosis or fever] 7.Malignancy 8.MI in preceding 12 months,unstable angina 9.Patient who were given plasma in perioperative period

Design outcomes

Primary

MeasureTime frame
Postoperative Hemoglobin dropTimepoint: Assessed at 3 days of surgery

Secondary

MeasureTime frame
Perioperative blood loss, need for post operative blood transfusion, impairment of renal function, occurrence of deep vein thrombosisTimepoint: 6 weeks

Countries

India

Contacts

Public ContactDr Jefferson George

Sunshine Hospitals, Secunderabad

jeffgeorge007@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026